EUVIMEDEUVIMED entdecken
Crossref

Nitazoxanide and Umbelliferone improves Imiquimod-induced psoriasis in Balb/C mice

Japneet Singh Purewal, Maheshkumar Borkar, Gaurav M Doshi

Bioorganic Chemistry · 2025

DOI: 10.1016/j.bioorg.2025.108397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025. Verfasst von Japneet Singh Purewal und 2 weiteren Autor:innen. Beteiligte Einrichtung: SVKM's Dr Bhanuben Nanavati College of Pharmacy, Department of Pharmacology, V.M. Road, Vile Parle (W), Mumbai, India. Hauptthemen laut MEDLINE: Psoriasis, Umbelliferones, Thiazoles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Department of Science and Technology, AICTE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Signal Transducer and Activator of Transcription (STAT) 3 is a significant contributor to the development and pathogenesis of psoriasis (Pso). Research demonstrated STAT3 signalling to be upregulated in Pso. Additionally, Pso results in oxidative stress that activates various signalling pathways like factor nuclear kappa-B (NF-κB). Nitazoxanide (NTZ) is an antiprotozoal drug shown to inhibit the STAT3 pathway. Umbelliferone (UMB) is an antioxidant, and anti-inflammatory and can suppress NF-κB signalling. Therefore, we propose to hypothesize that NTZ and UMB would be effective in treating Pso. Balb/c mice were treated with IMQ to induce Pso. The clinical characteristics of Pso were assessed using the Psoriasis Area and Severity Index (PASI), back skin thickness, spleen length and mass, and histology of the skin sample tissue. In addition, we measured the levels of interleukin-17 (IL-17), tumor necrosis factor-α (TNF-α), STAT3, and NF-κB. Furthermore, to gain the interaction of NTZ and UMB with STAT3, a detailed in-silico study has been performed. The impact of treatment on oxidative stress was evaluated by estimating the activity of superoxide dismutase (SOD) and catalase (CAT). The results demonstrate that mice subjected to IMQ-induced Pso exhibited positive responses to treatment with NTZ and UMB. Additionally, IL-17, TNF-α levels, STAT3, and NF-κB were decreased in NTZ and UMB-treated groups. SOD and CAT levels in NTZ and UMB groups were elevated. Our findings show that NTZ and UMB are potential therapeutic medications for Pso.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisUmbelliferonesThiazolesAnimalsMice, Inbred BALB CMiceImiquimodSTAT3 Transcription FactorNitro CompoundsMolecular StructureStructure-Activity RelationshipDose-Response Relationship, DrugNF-kappa B

Stichwörter der Autor:innen

CyclosporineDockingNitazoxanideOxidative stressPro-inflammatory cytokinesPsoriasisUmbelliferone

Substanzen

UmbelliferonesImiquimodnitazoxanideThiazolesSTAT3 Transcription Factor7-hydroxycoumarinNitro CompoundsStat3 protein, mouseNF-kappa B

Autor:innen und Institutionen

  • SVKM's Dr Bhanuben Nanavati College of Pharmacy, Department of Pharmacology, V.M. Road, Vile Parle (W), Mumbai, India.
  • SVKM's Dr Bhanuben Nanavati College of Pharmacy, Department of Pharmaceutical Chemistry, V.M. Road, Vile Parle (W), Mumbai, India.
  • SVKM's Dr Bhanuben Nanavati College of Pharmacy, Department of Pharmacology, V.M. Road, Vile Parle (W), Mumbai, India. Electronic address: gaurav.pharmacology@gmail.com.

Förderung

  • Department of Science and Technology
  • AICTE

Zitieren

APA

Purewal, J. S., Borkar, M., & Doshi, G. M. (2025). Nitazoxanide and Umbelliferone improves Imiquimod-induced psoriasis in Balb/C mice. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.108397

Vancouver

Purewal JS, Borkar M, Doshi GM. Nitazoxanide and Umbelliferone improves Imiquimod-induced psoriasis in Balb/C mice. Bioorganic Chemistry. 2025. doi:10.1016/j.bioorg.2025.108397

BibTeX
@article{Purewal2025,
  author = {Purewal, Japneet Singh and Borkar, Maheshkumar and Doshi, Gaurav M},
  title = {Nitazoxanide and Umbelliferone improves Imiquimod-induced psoriasis in Balb/C mice},
  journal = {Bioorganic Chemistry},
  year = {2025},
  doi = {10.1016/j.bioorg.2025.108397}
}
Kostenlos starten →